论文部分内容阅读
目的 探讨经皮左锁骨下动脉行导管药盒系统 (PCS)植入术治疗晚期肿瘤的临床价值。方法 对 8例晚期肿瘤患者施行经皮左锁骨下动脉穿刺PCS植入术。术后经PCS每隔半个月行规律性化疗和免疫治疗加碘油乳剂栓塞治疗 ,以观察其疗效。结果 6例患者置管成功 (6 / 8) ,2例因血管走行严重变形 ,改从股动脉置管 ,留置管通畅率 (7/ 8) ,所有病例经半年多临床观察无 1例留置管滑脱、移位 ,植入药盒部位无 1例感染 ,切口愈合良好。 8例PCS植入后经半年观察转移病灶均有不同程度缩小 ,全身情况改善 ,生活均能自理。结论 经皮左锁骨下动脉行PCS植入术为晚期肿瘤患者提供了长期动脉内化疗灌注和碘油化疗乳剂栓塞的良好途径。
Objective To investigate the clinical value of percutaneous left subclavian artery catheterization kit (PCS) implantation in the treatment of advanced cancer. Methods Percutaneous left subclavian artery puncture PCS implantation was performed in 8 patients with advanced cancer. Postoperative PCS every two weeks regular chemotherapy and immunotherapy plus lipiodol emulsion embolization to observe its efficacy. Results Six patients had successful catheterization (6/8). Two patients suffered severe deformation due to the vascular movement. The catheterization was changed from the femoral artery to indwelling patency rate (7/8). All patients underwent more than half a year of clinical observation without any indwelling catheter Slippage, displacement, implantation of the cartridge site without infection in 1, the incision healed well. Eight cases of PCS implanted after six months of metastasis were observed to reduce the extent of metastasis, improve the general condition, life can take care of themselves. Conclusion The percutaneous left subclavian artery PCS implantation provides a good way for long-term intra-arterial chemoembolization and iodoform oil emulsion embolization for advanced cancer patients.